$AMRN Company News Expedia falls on Google penalty; Alcoa

New Post Public Reply Private Reply Replies (0) Message Board

Jan 27, 2014 at 11:03 AM

$AMRN Company News

Expedia falls on Google penalty; Alcoa jumps on upgrade 3:54 p.m. Jan. 21, 2014 - Sue Chang
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis
6 gut checks before the stock market's opening bell 6:12 a.m. July 8, 2013 - Shawn Langlois
6 gut checks before the stock market's opening bell 6:55 a.m. March 27, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 7:05 a.m. Feb. 27, 2013 - Shawn Langlois
Friday’s big movers: Groupon soars on Google talk 4:38 p.m. Dec. 7, 2012 - Sue Chang
Amarin down 17% on risks tied to drug launch 8:00 a.m. Dec. 7, 2012 - Steve Gelsi
Amarin down 18% in premarket trades 7:41 a.m. Dec. 7, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 3:40 p.m. Oct. 10, 2012 - Sue Chang
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Amarin issues patent update on fish-oil drug 11:29 a.m. Sept. 5, 2012 - Val Brickates Kennedy
Amarin jumps 16% after business update 11:06 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin rallies 15% on business update 9:48 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin falls 11% on insider stock-sale reports 11:12 a.m. July 31, 2012 - Val Brickates Kennedy
Amarin, AuthenTec active; advancers outpace decliners 4-1 on NYSE 11:45 a.m. July 27, 2012 - blogs.marketwatch.com
Amarin down 9% in wake of drug approval 9:08 a.m. July 27, 2012 - Val Brickates Kennedy
Amarin gets FDA approval for Vascepa 5:09 p.m. July 26, 2012 - Wallace Witkowski
Amarin: FDA OKs Vascepa for high triglycerides 4:46 p.m. July 26, 2012 - Wallace Witkowski
Amarin halted ahead of FDA decision deadline 2:13 p.m. July 26, 2012 - Val Brickates Kennedy

Amarin Tumbles after DMEP Decision - Analyst Blog 5:10 p.m. Jan. 22, 2014 - Zacks.com
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog 1:01 p.m. Jan. 22, 2014 - Zacks.com
Get set for capital raise at Amarin after ANCHOR SPA rejection 11:23 a.m. Jan. 21, 2014 - Seeking Alpha
FDA To Amarin: 'I Said Good Day, Sir!' 10:10 a.m. Jan. 21, 2014 - Seeking Alpha
FDA division won't reinstate SPA for Amarin's Vascepa 7:47 a.m. Jan. 21, 2014 - Seeking Alpha
Amarin Announces FDA DMEP Does Not Plan to Re-instate ANCHOR SPA Agreement 4:46 a.m. Jan. 21, 2014 - benzinga.com
Amarin: Is No News Good News? 4:13 p.m. Jan. 20, 2014 - Seeking Alpha
Amarin -5% after FDA delays ANCHOR SPA appeal, MKM downgrades 12:41 p.m. Jan. 16, 2014 - Seeking Alpha
February 14th Options Now Available For Amarin (AMRN) 10:57 a.m. Jan. 16, 2014 - TheStreet.com
Benzinga's Top #PreMarket Losers 7:22 a.m. Jan. 16, 2014 - benzinga.com
Amarin Delay Piques Investor Interest And Sparks Debate 4:12 a.m. Jan. 16, 2014 - Seeking Alpha
Regulator delays decision on Amarin's Vascepa 4:10 p.m. Jan. 15, 2014 - Seeking Alpha
Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed 3:05 p.m. Jan. 15, 2014 - benzinga.com
Stock Watch Monday, 13 January 2014: Intercept Soars As Focus Shifts To Healthcare Market Trends 9:06 a.m. Jan. 13, 2014 - Seeking Alpha
Amarin Out, Intercept Pharma In At J.P. Morgan Healthcare Confab 11:35 a.m. Jan. 12, 2014 - TheStreet.com
While Amarin Continues To Go Rancid, Neptune Will Soar 8:34 a.m. Jan. 11, 2014 - Seeking Alpha
Stock Watch Friday, 10 January 2013: Mannkind Rallies, Sirius Should Satisfy 8:36 a.m. Jan. 10, 2014 - Seeking Alpha
The Twitterverse's Biotech Stock Picks for 2014 8:00 a.m. Jan. 7, 2014 - TheStreet.com
Small Cap BioPharmas With Near Term Catalysts 7:55 a.m. Jan. 3, 2014 - Seeking Alpha
AMRN January 10th Options Begin Trading 11:43 a.m. Jan. 2, 2014 - TheStreet.com

Amarin Announces FDA Review Division Response to ANCHOR SPA Agreement Reinstatement Request 1:00 a.m. Jan. 21, 2014 - GlobeNewswire
Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed 4:05 p.m. Jan. 15, 2014 - GlobeNewswire
Equity Technical Dimensions:Seattle Genetics, Amarin, and PerkinElmer 8:00 a.m. Dec. 27, 2013 - PR Newswire
New Drug Application Updates, Appointments, Partnership Programs, and Stock Movements - Research Report on Amarin, Oramed Pharmaceuticals, Synta Pharmaceuticals, Healthways and AMN Healthcare 8:00 a.m. Dec. 25, 2013 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and of a Lead Plaintiff Deadline of January 3, 2014 3:29 p.m. Dec. 24, 2013 - PR Newswire
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Amarin Corporation plc of Upcoming Deadline 11:27 a.m. Dec. 20, 2013 - BusinessWire
Important Trend Analysis: Amarin Corporation plc, Corporation, Geron Corporation, 3D Systems Corporation 10:22 a.m. Dec. 20, 2013 - ACCESSWIRE
Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed 6:00 a.m. Dec. 20, 2013 - GlobeNewswire
SHAREHOLDER ALERT: Brower Piven Announces the Filing of a Class Action Lawsuit Against Amarin Corporation plc Expanding the Class Period to Include July 9, 2009 Through October 16, 2013 and Encourages Investors Who Have Losses in Excess of $150,000 From Investment in Amarin Corporation plc to Inquire About the Lead Plaintiff Position Before the January 3, 2014 Lead Plaintiff Deadline -- AMRN 4:59 p.m. Dec. 19, 2013 - GlobeNewswire
Amarin Announces Leadership Changes 9:07 a.m. Dec. 16, 2013 - GlobeNewswire
Glancy Binkow & Goldberg Files Class Action Lawsuit Against Amarin Corporation 9:32 p.m. Dec. 13, 2013 - BusinessWire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and a Lead Plaintiff Deadline of January 3, 2014 6:27 p.m. Dec. 11, 2013 - GlobeNewswire
Proposed Offering and Amendments, Patents, Results, and Announcements by Healthcare Companies - Research Report on Forest Laboratories, OncoMed, EnteroMedics, Cadence, and Amarin 8:00 a.m. Dec. 6, 2013 - PR Newswire
Biotech Briefing: Advancing Biotechs Forging Ahead With Breaking News Developments: Alliqua, OncoMed Pharmaceuticals, EnteroMedics, Unilife, Amarin 9:05 a.m. Dec. 4, 2013 - PR Newswire
Amarin Announces Notification of Patent Allowances for U.S. Applications 13/685,281, and 13/685,291 Related to Triglyceride Lowering With a Mixture of Omega-3 Free Fatty Acid (Including EPA and/or DHA) in Both the MARINE and ANCHOR Patient Populations 6:00 a.m. Dec. 2, 2013 - GlobeNewswire
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Amarin Corporation plc 9:32 p.m. Nov. 27, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Amarin Corporation, plc and Certain Officers - AMRN 4:56 p.m. Nov. 27, 2013 - PR Newswire
Kantrowitz, Goldhamer & Graifman, P.C. Files Class Action Suit Against Amarin Corporation plc 3:44 p.m. Nov. 27, 2013 - BusinessWire
AAAResearchReports.com Pre-Market Technical Analysis: Elan Corp., Amarin Corp., Cubist Pharmaceuticals, and Seattle Genetics 8:00 a.m. Nov. 27, 2013 - PR Newswire
Bullish Stocks Commentary: Camtek Ltd, Lions Gate Entertainment, ImmunoCellular Therapeutics, Pandora Media, Amarin Corporation 8:47 a.m. Nov. 26, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Meta's Bold Move: $25B Offering and New Stocks

Meta's New Financial Adventure Well, when Meta talks money, you better believe the market listens. This time, they’ve got a whopping pair of offerings on the table—one for depositary shares and another for their Class A common stock. Meta, under the ticker NASDAQ:META, isn't holding back, with a $25 billion upsized offering that's bound to rattle some cages. A Deeper...

Perfect Companion Expands Amid Ohio's Growing Elderly Needs

Riding the Aging Wave in Columbus The Perfect Companion is no stranger to the ups and downs of the eldercare industry. Celebrating five years in Columbus, this eldercare outfit's trying to pull off what many can't—a solid expansion in a landscape where finding reliable home care employees is about as easy as pulling teeth. But here they are, aiming to hire 25 more...

Navigating Market Uncertainty with Financial Planning

Staying Calm Amid Market Chaos The market's like a roller coaster more often than not, and when headlines scream panic, even the most seasoned of us can begin to doubt our strategies. Jennifer Prosise from The Voyager Group, Ltd., in Joliet, IL, calls out this high-stakes game in HelloNation, emphasizing how financial planning serves as our anchor in the stormy seas of...

IBSSC 2026: A New Chapter in Business Education

Shifts in Business Education at the IBSSC 2026 Boy, oh boy, Shanghai was buzzing the other week. We’re diving into the heart of the 11th International Business School Shanghai Conference (IBSSC). There's a changing of the guard in how business education is viewed, and it was all happening from October 21 to 23 at the Xuhui campus of Shanghai Jiao Tong University. Global...

Classet and Reelist Revamp Frontline Hiring Methods

Social Media's New Role in Hiring Who'd have thought? Scrolling through cat videos now lands you a job interview. The partnership between Classet and Reelist has thrown the hiring game a curveball, offering a seamless ride from a hashtagged post to a phone chat with an AI recruiter named Joy—and all in record time. For those looking to hire frontline or skilled trades...

USDA Loans in Pampa: Clearing Up Misconceptions

Understanding USDA Loans in Pampa When it comes to buying a home in Pampa, Texas, there's a lot of chatter about USDA loans, and a fair bit of confusion too. Now, real estate expert Patti Hudson is cutting through the noise and setting the record straight, making sure families know all the facts before diving into the housing market. Not Just for Rural Areas Let's squash...

Patriot Growth Welcomes Rajeev Jain: Operational Excellence

Shifting Gears: Patriot Growth's New Leadership Turn When it comes to tightening the ship and pointing towards uncharted waters, new leadership can be the key. This couldn't be more true for Patriot Growth Insurance Services as they welcome Rajeev Jain aboard as their latest Chief Operating Officer. This move is all about reinforcing their commitment to operational...

Envista's 2025 Sustainability Report: Key Takeaways

Envista's Green Drive: Numbers Tell the Story Whoever said numbers don't lie must've had reports like Envista's 2025 Sustainability Report in mind. This isn't just a glossy PR piece; it's a gritty reveal on how a company can clean house while cranking out progress in dental care. From the heart of Brea, California, Envista Holdings Corporation (NYSE:NVST) proves it's not...

Ensign Group Faces Securities Fraud Lawsuit Amid Scandal

Ensign's Legal Storm: Investors on Edge Man, you can't ignore the weighty allegations pounding on Ensign Group's door right now. The skilled nursing giant, under the ticker NASDAQ:ENSG, is feeling the heat from a securities class action filed against them, and my gut tells me this isn't going to blow over quietly. This case sure looks like a financial tempest that could...

Home EV Charging Demands Better Electrical Solutions

Power Plays in the Dallas Electrical Scene There's a new wrinkle for folks in Dallas slapping Level 2 EV chargers onto their garages. Seems like the plug-in station ain’t the only piece of the puzzle, and Safe Plug Electric is pointing its flashlight at a less obvious snag—electrical capacity. They're preaching from Garland to any soul across Dallas and Collin County...